This study aims to investigate the epidemiological characteristics and biomarkers of Clostridium difficile infection in infants . By analyzing historical medical data and patient questionnaires, this retrospective cohort study will identify potential high-risk factors and establish baseline biomarkers to improve diagnosis and treatment for affected patients.
Eligibility
Sex
ALL
Min age
0 Months
Max age
24 Months
Healthy volunteers
No
Inclusion Criteria:
* Infants ( aged 0-2 years). Medical records and patient questionnaires available with confirmed Clostridium difficile infection (for case group) or without infection (for control group).
Exclusion Criteria:
* Infants beyond the age of 2 years at the time of diagnosis. Incomplete medical records or missing essential information related to infection status, feeding methods, or antibiotic exposure.Patients with other severe gastrointestinal conditions that may confound results.
Primary outcome measure(s)
Number of Infants With Identified High-Risk Factors for Clostridium difficile Infection (CDI) — Retrospective data review spanning from initial exposure to Clostridium difficile infection up to 12 months post-diagnosis. This measure reports the number of infants with high-risk factors associated with Clostridium difficile infection (CDI), as assessed by data on feeding methods, antibiotic use, and environmental exposures. Quantitative data will be analyzed to identify correlations and trends.
Trial sites (1)
Facility
City
Region
Status
Hangzhou First People's Hospital
Hangzhou
Zhejiang, China
Recruiting
More First People's Hospital of Hangzhou trials in China
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.